Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
166
-
Total 13F shares, excl. options
-
75,095,879
-
Shares change
-
+796,219
-
Total reported value, excl. options
-
$2,991,389,896
-
Value change
-
+$33,191,074
-
Put/Call ratio
-
109%
-
Number of buys
-
70
-
Number of sells
-
-84
-
Price
-
$39.83
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q4 2021
198 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q4 2021.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75,095,879 shares
of 80,437,135 outstanding shares and own 93.4% of the company stock.
Largest 10 shareholders include FMR LLC (10,604,685 shares), WELLINGTON MANAGEMENT GROUP LLP (8,155,047 shares), VANGUARD GROUP INC (6,888,909 shares), BlackRock Inc. (6,389,941 shares), RTW INVESTMENTS, LP (5,293,966 shares), FRANKLIN RESOURCES INC (4,881,214 shares), JANUS HENDERSON GROUP PLC (3,901,397 shares), STATE STREET CORP (2,801,431 shares), BANK OF AMERICA CORP /DE/ (2,634,134 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2,106,561 shares).
This table shows the top 166 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.